Neurizon Therapeutics LimitedASX: NUZ

Withdrawal of Resolution 4 from Notice of AGM

· Issued by Neurizon Therapeutics Limited via ASX

Filed with ASX · · 1 page · English

Summary by 6ix AI

Neurizon Therapeutics Limited has announced the withdrawal of resolution four from its Notice of Annual General Meeting. This resolution pertained to the approval for issuing convertible notes to Obsidian Global GP, LLC and will not be voted on at the AGM. The withdrawal is due to a capital raising announced earlier on the same day. Shareholders do not need to take any action regarding this withdrawal, and the AGM will proceed as scheduled.

Written by 6ix AI from the company’s filing. How 6ix writes summaries

On 6ix: 6ix.com/news/withdrawal-of-resolution-4-from-notice-of-agm

Release

Neurizon Therapeutics Limited ABN 35 094 006 023 www.neurizon.com Withdrawal of Resolution 4 from Notice of Annual General Meeting 2 November 2026 – Melbourne, Australia: Neurizon® Therapeutics Limited (ASX: NUZ, OTCQB: NUZTF) (“Neurizon” or “the Company”), a late clinical-stage biotech...

Neurizon Therapeutics Limited on 6ix

Story so far

Earlier from Neurizon Therapeutics

Later from Neurizon Therapeutics

All Neurizon Therapeutics news releases